This spring, a group of experts plans to examine a range of measures to tackle drug shortages in Switzerland. Some of the measures up for discussion include simplifying authorisations, closer supply monitoring, and stronger international networking. +Get the most important news from Switzerland in your inbox The group of experts chaired by Bernhard Pulver, former member of the cantonal government of Bern and President of the Insel Group, has completed its work with a report. The government was informed of this in a press release on Wednesday. Specifically, the group of experts recommends, for example, simplifying the administrative requirements for the authorisation of medicines. Another proposal concerns the possibility of authorising foreign packaging in order to remove obstacles that can lead to supply bottlenecks or market withdrawals. The expert group also proposes monitoring medicinal products according to their therapeutic relevance, securing existing, important production ...
